Intravitreal Triamcinolone Versus Bevacizumab for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
Hosoong Kim, Sangjung Moon, Jaehoon Kang, Heesung Yoon
J Korean Ophthalmol Soc. 2010;51(8):1071-1076.   Published online 2010 Aug 15     DOI: https://doi.org/10.3341/jkos.2010.51.8.1071
Citations to this article as recorded by Crossref logo
A Comparison of Three Intravitreal Modalities of Branch Retinal Vein Occlusion Macular Edema
Han Song, Hee Jun Song, Ji Ho Yang, Do Gyun Kim
Journal of the Korean Ophthalmological Society.2018; 59(9): 834.     CrossRef
Comparison of Bevacizumab and Combined Low-dose Bevacizumab and Triamcinolone in Central Retinal Vein Occlusion
Byung Jae Kim, Hyun Woong Kim, Yong Seop Han, Jong Moon Park, In Young Chung
Journal of the Korean Ophthalmological Society.2016; 57(3): 438.     CrossRef
Clinical Features According to the Occlusion Site in Patients with Branch Retinal Vein Occlusion
Ka Hee Park, Kyung Seek Choi
Journal of the Korean Ophthalmological Society.2013; 54(8): 1248.     CrossRef
Combined Therapy of Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injection in Macular Edema with Branch Retinal Vein Occlusion
Aran Cho, Kyung Seek Choi, Mi Ri Rhee, Sung Jin Lee
Journal of the Korean Ophthalmological Society.2012; 53(2): 276.     CrossRef
Prognostic Factors after Intravitreal Triamcinolone Injection for Macular Edema due to Branch Retinal Vein Occlusion
Suk Jin Kim, Yeon Sung Moon
Journal of the Korean Ophthalmological Society.2012; 53(1): 49.     CrossRef